Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T cell therapy: Where are we now, and where are we heading?
Jiayi Wang, Liang Wang
Blood Science (2023) Vol. 5, Iss. 4, pp. 237-248
Open Access | Times Cited: 25

Showing 25 citing articles:

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Enrichment of CD4+ and CD8+ T-Lymphocytes with a Column-Free Flow Based Device for Clinical Cell Manufacturing
Paulina Langa, Kriti Sharma, David Sellers, et al.
Cytotherapy (2025)
Closed Access
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
Tingting Yue, Yue Sun, Yun Dai, et al.
Blood Reviews (2025), pp. 101256-101256
Closed Access
Aging impairs CD8 T cell responses in adoptive T-cell therapy against solid tumors
Gulfiya Kadyrzhanova, Miho Tamai, Shukla Sarkar, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Recent development in treatment strategies for breast cancer: With special reference to immunotherapy
Riya Sharma, Jaishree Karnwal Tiwari, Parvesh Kumari, et al.
Elsevier eBooks (2025), pp. 131-147
Closed Access
The Evolving Landscape in Multiple Myeloma: From Risk Stratification to T Cell-Directed Advanced Therapies
Carmen Besliu, Alina Tănase, Ionela Rotaru, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 525-525
Open Access
Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
Anna De Lucia, L. Mazzotti, Anna Gaimari, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Antifungal immunity: advances in PRR recognition, adaptive responses, and immune-based therapies
Jianlin Zhou, Xinjie Lu, Rui-Rui He, et al.
Science China Life Sciences (2025)
Closed Access
Unraveling the triad of immunotherapy, tumor microenvironment, and skeletal muscle biomechanics in oncology
Shuang Ma, Ying Lü, S.J. Sui, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hemoadsorption as a Supportive Strategy for Severe Toxicity Associated With Chimeric Antigen Receptor T Cell Therapy: A Case Series
Pasquale Esposito, Massimiliano Gambella, Elisa Russo, et al.
Kidney Medicine (2025), pp. 101001-101001
Open Access
Unmet needs and lived experience of patients receiving CAR T-cell therapy
P.G. O’Shea, P. Connor Johnson, Areej El‐Jawahri, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2025), pp. 1-11
Closed Access
Gene and Cell Therapy for Sarcomas: A Review
Sant P. Chawla, Stephen C. Pang, Dhawal Jain, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1125-1125
Open Access
Advancement in “Off-the-Shelf” CAR T-Cell Therapy for Cancer Immunotherapy
Mohsen Sheykhhassan, Anita Silas La’ah, Amirhossein Ahmadieh-Yazdi, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 33-92
Closed Access | Times Cited: 1
Acute kidney injury in hematological patients treated with CAR-T cells: risk factors, clinical presentation and impact on outcomes
Elisa Russo, Massimiliano Gambella, Anna Maria Raiola, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Recent advances and progress in immunotherapy of solid cancers
Amit Kumar, Luni Emdad, Swadesh K. Das, et al.
Advances in cancer research (2024), pp. 111-190
Closed Access
High percentage of bone marrow CD8+ tissue-resident-like memory T cells predicts inferior survival in patients with acute myeloid leukemia
Letong Cai, Wenpu Lai, Danlin Yao, et al.
Blood Science (2024) Vol. 6, Iss. 3, pp. e00194-e00194
Open Access
CAR-T Therapy can be a Useful Treatment Modality for more than Just Hematologic Malignancies
Kazuhiro Ikegame
Internal Medicine (2024)
Open Access
Targeting Tumors
Safiya Mehraj, Shazia Ali
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 93-122
Closed Access
Into the storm: the imbalance in the yin-yang immune response as the commonality of cytokine storm syndromes
Amy E. Armstrong, Yuting Tang, Neelam Mukherjee, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Molecular profiling and therapeutic tailoring to address disease heterogeneity in systemic lupus erythematosus
Abhibroto Karmakar, Uma Kumar, Smitha Prabhu, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access
Les cellules CAR-T anti-CD19: prototypes du médicament vivant1
Michel Sadelain, Isabelle Rivière
Bulletin de l Académie Nationale de Médecine (2024) Vol. 208, Iss. 9, pp. 1288-1298
Closed Access
BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1
Songnan Sui, Mengjun Zhong, Shuxin Zhong, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access
Juvenile Dermatomyositis: Updates in Pathogenesis and Biomarkers, Current Treatment, and Emerging Targeted Therapies
Hanna Kim
Pediatric Drugs (2024)
Open Access
Rapid manufacture of low-seed CAR-T cells in a GMP-grade hollow-fiber bioreactor platform
Kenneth Marshall, Melissa Mastro, Brian Nankervis, et al.
Cytotherapy (2024)
Open Access
CAR T-Cell Therapy for Rheumatic Diseases: What Does the Future Hold?
Jérôme Avouac, Marc Scherlinger
BioDrugs (2024)
Closed Access
Page 1

Scroll to top